Shruti Bhat PhD, MBA, Operational Excellence Expert
  • Home
  • About Shruti
  • Books
  • Insights
  • Operational Excellence
  • Articles
    • Innovation Management and R&D Leadership
    • Product Development
    • Business Transformation
    • Process Improvement
    • Business Continuity
    • Change Management
    • Digital Transformation
    • Quality Improvement
  • Tools
    • Whitepapers
    • Checklists and Templates
    • Free eBook
    • Videos
  • Engage Shruti
    • Consulting >
      • Operational Excellence Consulting
      • Business Transformation Consulting
      • Innovation Management Consulting
    • Workshops
  • Case Studies
  • Blog
  • Contact

CHEMISTRY OF PEPTIDES

5/29/2009

0 Comments

 
Structural aspects of peptide based drugs: 

Peptide history predates to 1906 when Emil Fischer coined the name “peptide” to describe the products formed on linking aminoacids via amide or peptide bonds.  The term polypeptide refers to the peptides, which contain eight or more amino acids whereas oligopeptides are those, which have less than 8 amino acids.  Polypeptides that contain from about 50-2500 amino acids are termed proteins. Proteins with 2 or more polypeptide chains are known as oligomeric proteins, their component chains are called subunits or protomers. 

Current methods of peptide synthesis: 

There are several techniques currently available for the synthesis of peptides and proteins.  They include:

i.       Classical solution based methods.

ii.       Solid phase methods.

iii.      Enzyme methods.

iv.      Semi-synthetic methods and 

v.      Recombinant methods.

The routes of synthesis are not general and the choice of method depends upon the target molecule under investigation.

Purification of peptides:

There are many acceptable, well-practiced ways of purifying peptides to produce products suitable for administration by parenteral and/or other non-invasive routes.  In other words, the peptides should be pyrogen free, non-antigenic and preferably sterile.  Purification procedures are based on the individual characteristics of the target sequence and the type of impurities likely to be associated in the polypeptide molecule.  The impurities basically originate from 2 quarters viz. 

1.      Source derived impurities and

2.     Process derived impurities and lead to several pharmacological regularities such as oncogenesis, pyreia, tumors etc. The type of adverse effects produced is of course dependent on the type of impurity. The purification procedures therefore exploit the differences in the peptide size, shape, solubility, hydrophobicity or affinity to solvents. 

​
Characterization of peptides: 

Determination of a protein’s amino acid sequence is often performed as a confirmation of the proteins structure, since the arrangement of sequence of amino acids in the protein largely characterizes the unique properties of these molecules particularly with respect to their biologic activity.  That the arrangement of amino acids can have a powerful effect upon the behavior of proteins molecules has been spectacularly demonstrated by the results of mutations that can cause as a result of deletion or change of a single amino acid.  The best-known example of this property is probably the disease sickle-cell anemia, caused by such a defect in hemoglobin synthesis.  Another example of this structural identity of proteins is platelet derived growth factor with sis-oncogene, which provided insight into the molecular basis of tumorigenesis. 

Protein micro sequencing can be performed by classical Edman degradation technique. Progressive protein micro sequencing has also been achieved using polyacrylamide gel electrophoresis, mass spectroscopy, electrochemical detection as well as Fast atom bombardment mass spectroscopy (FAB-MS).  However, there is no single analytical technique that can be used in isolation to characterize a peptide unambiguously. The greater the number of analytical procedures to which a peptide product can be subjected, the more certain the user can be of its purity and authenticity.

In the next post I shall discuss estimation of peptide and protein molecules. ​
​Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement
    To contact Dr. Shruti Bhat text or WhatsApp at 1.403.969.6219

    New Book Released!

    Revolutionizing Industries with Lean Six Sigma

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    Agile
    Artificial Intelligence
    Automation
    Biotechnology
    Books
    Business Continuity
    Business Turnaround
    Case Studies
    Change Management
    Checklists
    Chemical Industry
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    Insights
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    MSMEs
    Nanotechnology
    Operational Excellence
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    R&D Leadership
    Robotics
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    Templates
    TQM
    Videos
    Voice Of Customer
    Whitepaper
    Workshops

    Shruti's books...

    Picture
    top ten strategic decision-making tools for operational excellence
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    how to lead a successful business transformation
    leading organizations through crisis
    emotional intelligence
    how to overcome challenges of creating effective teams
    modular kaizen Vs Blitz kaizen
    How to increase employee engagement as a new boss

    ​Micro-Learning
    ​Partner

    Picture

    Wellness
    ​Partner

    Picture

Connect with Dr. Shruti Bhat at- ​Twitter, YouTube, LinkedIn​

© Copyright 1992- 2025 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
Subscribe to Operational Excellence Academy YouTube Channel
​Subscribe to Operational Excellence Academy YouTube Channel
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media